Last €22.21 EUR
Change Today -0.293 / -1.30%
Volume 413.7K
As of 3:28 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Manfred E. Karobath M.D.

Supervisory Director and Chairman of Compensation Committee, Qiagen NV
AgeTotal Calculated CompensationThis person is connected to 19 board members in 3 different organizations across 3 different industries.

See Board Relationships


Dr. Manfred E. Karobath, M.D. served as the President of research and development and Executive Vice President of Rhne-Poulenc Rorer (now sanofi-aventis), a pharmaceutical company, from 1992 to 1999. In 1980, Dr. Karobath joined Sandoz Pharma in Basel, first, in drug discovery and later became Senior Vice President and Head of R&D, Switzerland. Dr. Karobath serves as the Chairman and Director of IDEA AG and Director of Cardion AG. Dr. Karobath has been a Supervisory ...

Read Full Background

Corporate Headquarters*

Spoorstraat 50
Venlo, Limburg 5911 KJ


Phone: 31 77 320 8400
Fax: --

Board Members Memberships*

Chairman of the Board and Member of Supervisory Board
Director and Member of Compensation Committee


Bachelor's Degree
Universitat Wien
University of Vienna Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options28,341
Unexercisable Options1,494
Total Number of Options29,835

Total Compensation*

Total Annual Cash Compensation$66,400
Total Calculated Compensation$66,400
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QIA:GR €22.21 EUR -0.293


John L. Bishop Chairman, Chief Executive Officer and Member of Equity Incentive Committee
Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
Norman D. Schwartz Chairman, Chief Executive Officer and President
Bio-Rad Laboratories, Inc.
Robert F. Friel Chairman, Chief Executive Officer, President and Member of Finance Committee
PerkinElmer Inc.
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QIAGEN N.V., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at